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Rationale: Developmental vitamin D (DVD) deficiency has been proposed as a risk 
factor for schizophrenia. DVD-deficient rats show selective cognitive deficits and 
novelty-induced hyperlocomotion, and enhanced locomotor responses from acute 
treatment with psychomimetic drugs, such as amphetamine and MK-801. Here we 
wished to examine the effect of a drug from a different class of 
psychomimetic/psychoactive compounds, ∆9-tetrahydrocannabinol (THC), on tasks 
with relevance to the cognitive and positive symptoms of schizophrenia. 
Objectives: The aim of this study was to investigate whether DVD deficiency 
modulates the behavioural effects of THC on tests of delay-dependent memory, 
sensorimotor gating and locomotion. 
Methods: Adult control and DVD-deficient rats were injected with THC (0, 0.3, 0.6, 
1.25, 2.5 mg/kg) 15 min before a delay match to sample task (DMTS) using variable 
delays (0-24 s). A separate group of rats were injected with either 2.5 mg/kg THC or 
vehicle before tests of either prepulse inhibition (PPI) of the acoustic startle response 
(ASR) or in the open field.  
Results: Control and DVD-deficient rats showed a similar dose-dependent 
impairment in performance on the DMTS. The greatest impairment was seen at 2.5 
mg/kg at all delays (0-24s). DVD-deficient rats displayed THC-induced enhancement 
of PPI, which was not seen in control rats. There was no effect of maternal diet on 
ASR or locomotor responses in the open field.  
Conclusions: This study reports the novel findings that DVD-deficient rats were more 
sensitive to the acute effects of THC on PPI. It appears that prenatal vitamin D 
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Introduction 
Schizophrenia is a complex, debilitating, yet poorly understood group of 
neuropsychiatric disorders, affecting approximately 1% of the population, with typical 
onset during late teens or early twenties (McGrath et al., 2008). Schizophrenia is 
characterised by positive symptoms, which include hallucinations and delusions, and 
negative symptoms, which include restricted affect and deficits in social drive, 
motivation, reward response and sense of purpose. Cognitive impairment is a non-
diagnostic core feature (Robbins, 2005) closely linked to the functional outcomes of 
patients (Green, 1996) and is seen across multiple domains, such as 
attention/vigilance, working memory, reasoning and problem solving (Nuechterlein et 
al., 2005).  
 
Epidemiological studies have identified environmental exposures that lead to an 
increased risk of developing schizophrenia. These include pregnancy and birth 
complications (Carpenter & Buchanan, 1994), cannabis abuse (Arseneault et al., 
2002), and nutritional deficiencies, such as hypovitaminosis D (McGrath, 1999). 
Based on various clues from schizophrenia epidemiology, McGrath (1999) proposed 
that low pre- and peri-natal vitamin D concentrations may be a risk factor for 
schizophrenia. A population-based case-control study (McGrath et al., 2010) found a 
two-fold risk of schizophrenia in those in the lowest quintile of 25 hydroxyvitamin D 
concentration (i.e. in the deficient range) versus those in the fourth quintile (i.e. 
adequate range). Not everyone with low neonatal vitamin D concentrations develops 
schizophrenia, suggesting that other factors (e.g. genetic and other nongenetic) 
contribute to risk status.  
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To test the biological plausibility of this hypothesis we have developed an animal 
model of developmental vitamin D (DVD) deficiency. In this model, the developing 
foetus is exposed to transient hypovitaminosis D during gestation only. The brains 
from DVD-deficient neonatal rats appear to develop abnormally having larger lateral 
ventricles (Eyles et al., 2003) and a variety of cellular outcomes indicating delayed 
development (Eyles et al., 2003; Ko et al., 2004; Cui et al., 2007). Behaviorally, adult 
DVD-deficient rats have an enhanced locomotor response to novelty (Burne et al., 
2004) and the psychomimetic MK-801 (a non-competitive NMDA antagonist) (Kesby 
et al., 2006; Kesby et al., 2012). This sensitivity is selectively diminished by the 
dopamine 2 (D2) receptor blocking agent, haloperidol (Kesby et al., 2006). 
Dopamine (DA) turnover along with the enzyme responsible for its metabolism, 
catechol-O-methyl-transferase, are altered in the DVD-deficient neonate brain 
(Kesby et al., 2009), and adult DVD-deficient rats show enhanced locomotor 
responses to amphetamine (Kesby et al., 2010). Thus, there would appear to be 
some evidence that both NMDA and dopaminergic systems are abnormal in this 
model consistent with the prominent hypotheses regarding abnormalities in these 
transmitter systems in schizophrenia (Olney & Farber, 1995; Toda & Abi-Dargham, 
2007). 
 
DVD-deficient rats also have selective cognitive deficits, such as impaired latent 
inhibition (Becker et al., 2005) suggesting a deficit in the ability to attend selectively 
to relevant stimuli. Latent inhibition refers to a phenomenon that involves learning to 
ignore a stimulus that is not associated with anything salient. Acutely psychotic 
patients have also shown impairments in latent inhibition (Gray et al., 1991; Lubow & 
Gewirtz, 1995) and DA agonists have been shown to decrease latent inhibition in 
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healthy adult males (Swerdlow et al., 2003). Moreover, DVD-deficient rats show 
increased impulsivity and a lack of inhibitory control when assessed in a 5-choice 
continuous performance task (Turner et al., 2013). The increased impulsivity in DVD-
deficient rats can also be attenuated with the atypical antipsychotic, clozapine.  
However, although DVD-deficient rats have been shown to have normal 
sensorimotor gating, as measured by prepulse inhibition (PPI) of the acoustic startle 
response (ASR) (Burne et al., 2004; Kesby et al., 2012), delay-dependent memory 
has not been investigated directly in this model. 
 
Cannabis reliably induces acute impairments in working memory in humans (Ilan et 
al., 2004) and acute THC administration consistently produces deficits on delay-
dependent memory tasks in rodents, using both delay matching to sample (DMTS) 
and non-matching to sample (DNMTS) tasks (Heyser et al., 1993; Mallet & Beninger, 
1998; Panlilio et al., 2011; Panlilio et al., 2012). The definition of working memory is 
different in humans and rodents; in humans it refers to a limited capacity to store 
information that also includes a central executive function for allocating attention, 
whereas in the rodent it is a time-dependent loss of relevance similar to short-term 
memory or goal maintenance (Dudchenko et al., 2013). With respect to psychosis, 
cohort studies have shown that the early use of cannabis increased the risk of later 
psychotic disorders (Arseneault et al., 2004). Moreover people with an underlying 
predisposition for a psychotic disorder may be at a greater risk of the psychotic 
effects of acute, and more commonly chronic, cannabis use. Several animal models 
related to schizophrenia have also reported differential sensitivity to cannabis. For 
example, in Sprague-Dawley rats, social isolation leads to behavioural and 
neurochemical alterations similar to those seen in schizophrenia, including impaired 
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PPI, which is frequently impaired in psychiatric disorders, including schizophrenia 
[30]. Socially-isolated rats treated acutely with the cannabinoid (CB) agonist ∆9-
tetrahydrocannabinol (THC, 3 mg/kg) show further impairments in both ASR and 
PPI, whereas there was no effect of THC on these measures in group-housed rats 
(Malone & Taylor, 2006). Moreover, the CB receptor agonist WIN 55,212-2 did not 
disrupt either ASR or PPI in group-housed Sprague-Dawley rats (Bortolato et al., 
2005). These data suggest that acute administration of a CB receptor agonist 
produces decreases in PPI in individuals that already have altered sensorimotor 
gating, but not in healthy controls. However, there are reports of CB receptor 
agonists affecting PPI in both directions; leading to a decrease (Malone & Taylor, 
2006) or an increase in PPI (Stanley-Cary et al., 2002).  
 
The aim of the current investigation was to examine delay-dependent memory, 
sensorimotor gating and locomotor responses after acute administration of THC in 
DVD-deficient and control rats. We first used a dose-response design to examine 
effects of THC on delay-dependent memory using a delay match to sample (DMTS) 
task. We show impaired performance at all delays on the DMTS after 2.5 mg/kg 
THC, but not at lower doses. Therefore, we selected this dose (2.5 mg/kg) and 
assessed separate groups of rats on ASR, PPI and open field tests to determine 
whether DVD-deficient rats showed an altered sensitivity to THC using these tasks. 
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Materials and methods 
Animals 
Adult Sprague-Dawley (SD) rats (The University of Queensland Breeding colony, St 
Lucia, Brisbane) were used for this experiment. Maternal vitamin D depletion was via 
a manipulation of dietary and lighting sources consistent with a previously described 
method (Eyles et al., 2011). Briefly, female rats were fed a vitamin D deficient diet 6 
weeks prior to conception and throughout gestation, and housed under incandescent 
lighting to avoid exposure to UVB radiation. At birth, all dams and corresponding 
litters were placed on a regular diet (Specialty Feeds, WA). Using this method, 
maternal and immediate post‐natal vitamin D is depleted, however offspring have 
regular vitamin D levels by two weeks of age and normal calcium, phosphorous and 
parathyroid hormone levels as adult rats (Eyles et al., 2011). Adult rats were pair-
housed in Macrolon cages with sanichip bedding and wire lids, on a 12h‐light-dark 
cycle (lights on at 0600h) and were food restricted to ~90% of free-feeding weight 1 
week prior to operant testing on the DMTS (Control male n=8, Control female n=8, 
DVD male n=7, DVD female n=6). Separate groups of non-food restricted and drug-
naive rats were used for the PPI (Control male n=8, Control female n=8, DVD male 
n=12, DVD female n=12) and open field tests (Control male n=12, Control female 
n=11, DVD male n=12, DVD female n=12). All rats were approximately 6 months of 
age when they were exposed to THC. All procedures were performed with approval 
from the Queensland University Animal Ethics Committee, under the guidelines of 
the National Health and Medical Research Council of Australia. 
All behavioural testing occurred between 08:00 –16:00 h under dim white light. THC 
(Lipomed, Arlesheim, Switzerland) was administered via intraperitoneal injection 
(i.p.) at 1 ml/kg. THC was made up in absolute ethanol, tween-80 and then diluted in 
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saline to a ratio of 1:1:18. The vehicle was absolute ethanol, tween-80 and then 
diluted in saline to a ratio of 1:1:18. THC or vehicle was administered 15 min before 
testing. Chambers were cleaned between tests with 70% ethanol and dried with 
paper towel.  
 
Delayed match to sample  
We examined delay-dependent memory using a DMTS task as described previously 
(Flagstad et al., 2005). Training and testing took place in six chambers 
(50x50x50cm, Med Associates Inc., St. Albans, VT, USA) situated in a room under 
dim white light. The chamber was housed in a ventilated, sound attenuated box and 
ventilated by a fan with background noise of 70dB presented from a speaker within 
the chamber. The rats were trained to press a lever for delivery of a 45 mg food 
pellet (F0021, dustless precision pellet, Bioserv, Frenchtown, NJ, USA) to a centrally 
located food magazine. The food magazine was fitted with a light and head entries to 
the magazine were recorded using an infrared beam. A house light was located on 
the ceiling directly above the food magazine. The control of stimuli and recording of 
responses were managed by SmartCtrl Packages 8-In/16-Out with additional 
interfacing by MED-PC for Windows (Med Associates Inc., St. Albans, VT, USA).  
Briefly, the task was conducted over separate stages. In the first stage the rats were 
trained to retrieve a food pellet from the illuminated food magazine. Next they were 
trained to respond to any lever when both were presented in the chamber. Behaviour 
was further shaped with food reward and the rats progressed through different 
stages until they reached baseline criteria for DMTS. The DMTS trial commenced 
when one of the two retractable levers (randomly selected) was presented in the 
chamber, accompanied by the corresponding cue light. This was defined as the 
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sample phase and the rat was required to press the lever within 20 s. The lever was 
then retracted and the rat had to nose-poke the illuminated food magazine. The rats 
were required to make a head entry into the magazine at the end of the delay to 
move to the choice phase. Because the end of the delay was not cued, the rats sat 
at the magazine performing rapid head entries until the delay period ended. This 
prevented the rats from staying in position in front of the lever from the sample 
phase. After a random variable delay phase (0, 2, 4, 8, 12, 18, 24 s), both levers 
were extended back into the chamber for the test phase for a maximum of 20 s. The 
correct response was to ‘match to sample’ and the rat was required to push the 
same lever that was extended in the sample stage, to which a food pellet was 
dispensed and the food magazine lit up. An incorrect response to the other, ‘non-
match to sample’ lever resulted in a time out, during which the house light was 
illuminated. If neither lever were pressed then the trial was scored as null and 
excluded from the analysis (Mallet & Beninger, 1998). After a 5 s intertrial interval 
(ITI) the next trial commenced. The time taken to have learnt the procedure was 
defined as the number of sessions from the first day of training to reach criteria on 
the final training step. Once a stable level of performance was reached (25 sessions) 
each rat was administered with escalating doses of THC in vehicle (0, 0.3, 0.6, 1.25, 
2.5 mg/kg) with two injection test days (saline and then vehicle) between each dose. 
We recorded percent correct (number of correct trials as a proportion of trials 
completed), percent null trials (number of null trials divided by the total number of 
trials commenced), reward latency and head entries into the magazine.  
 
Prepulse inhibition of the acoustic startle response 
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ASR and PPI of the ASR were assessed in a separate group of drug-naïve rats 
using four startle chambers (SR-LAB, San Diego Instruments, CA, USA) consisting 
of a plexiglass cylinder (9 cm diameter) mounted on a plexiglass frame with a 
piezoelectric accelerometer mounted below; in a ventilated, light-free enclosure (30 x 
30 x 30 cm). Background noise was maintained at 70 dB and acoustic bursts of 
white noise were delivered via a speaker mounted 20 cm above the animal. PPI was 
tested using a within-subject design. The first day was used to habituate the animals 
to the apparatus. On the second day the rats were treated with vehicle, and the third 
day treated with THC (2.5 mg/kg). After 4 days of washout the rats were given a final 
PPI session to re-establish baseline responses. This method for assessing ASR, PPI 
and habituation of ASR within the same testing session, has been adopted 
previously (Burne et al. 2004b; Kesby et al. 2006). Briefly, testing sessions consisted 
of a 5 min acclimation period at 70 dB to assess background level of activity, 
followed by five startling pulses (110 dB), each 20 s apart. Subsequently, five blocks 
of 24 trials were presented, including six pulse-alone trials to assess ASR (70, 80, 
90, 100, 110 and 120 dB) and 18 different trial types with a pre-pulse to assess PPI. 
Pre-pulses had intensities of 74, 78 or 86 dB with a range (8, 16, 32, 64, 128 or 256 
ms) of pre-pulse to pulse intervals to assess maximal PPI. The pulse was presented 
for 40 ms and the pre-pulse presented as a 20 ms broad band burst. The sequence 
of inter-trial intervals, which varied between 10-20s, was initially allocated randomly, 
and then edited to ensure identical intervals did not occur consecutively. Testing 
ended with the replication of initial startling pulses (110 dB), allowing for the 
assessment of within-test habituation of the ASR. The startle response was a 
measure of the average amplitude, using the median value of the five blocks of each 
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trial type. PPI was assessed using the formula: [(amplitude of trial without pre-pulse 
– amplitude of trial with pre-pulse)/amplitude of trial without pre-pulse] x100.  
 
Open Field 
Locomotion and exploration was assessed simultaneously using six clear chambers 
45 x 45 cm wide and 30 cm deep and tracked with Ethovision v5.1. Separate groups 
of drug-naïve rats were administered 2.5mg/kg THC (Sigma Aldrich, MO, USA) or 
vehicle via intraperitoneal injection (i.p.) at 1ml/kg 15 min before the animal was 
placed in the activity monitor for 90 min. Arenas were cleaned between tests with 
70% ethanol and dried with paper towel.  
 
Statistical analysis 
Baseline behavioral measures were assessed with a two-way analysis of variance 
(ANOVA) with main effects of Sex and Maternal Diet. For the DMTS, ASR and PPI 
data we used separate three-way ANOVA to analyze data with main effects of Sex 
and Maternal Diet with a repeated measure on the factor Drug due to the within 
animal design. There were no Sex x Diet interactions and so all data were pooled for 
sex. Significant effects were followed up by post-hoc tests with Bonferroni correction 
for multiple comparisons. Values of p < 0.05 were considered to be significant. All 
data are reported as mean  standard error of the mean (S.E.M.).  
 
Results 
Effect of THC on DMTS 
There was no significant effect of Maternal Diet on the time taken to reach criteria for 
DMTS or on the total number of rewards received. There was no significant effect of 
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Maternal Diet for any parameter measured on baseline performance of the DMTS 
(percent correct, percent null trials, head entries, reward latency). The performance 
of both groups decreased with increasing delay, and it was during these longer delay 
periods that rats made more head entries and head entry latency increased in 
proportion to delay duration (data not shown). Following treatment with THC, the 
percent of correct trials was significantly reduced at all delays in control and DVD-
deficient rats at the highest dose of THC administered (2.5 mg/kg, F4,100=5.99, 
p<0.001, Fig. 1; Fig 2a). There was a significant effect of THC (but not Diet) on the 
percent of null trials (F4,108=8.24, p<0.001; Fig. 2b) but no significant effect of THC or 
Maternal diet on the latency to collect the reward (data not shown). We also 
examined the performance of rats on vehicle session (between drug test days) and 
there was no significant change in performance over time when we assessed the 
between-drug vehicle testing sessions (F4,21=1.17, p=0.35, Fig. 2c). 
 
<<Insert Fig. 1 and Fig. 2 near here>> 
 
Effect of THC on PPI 
All rats responded to increasing pulse amplitude with increased startle response. 
Overall, there was no significant effect of Maternal Diet (F1,38=1.25, p=0.27) or THC 
(F1,38=0.6, p=0.44) on the acoustic startle response (Fig. 3). There was no significant 
effect of Maternal Diet on PPI scores at baseline or after treatment with vehicle. 
There was a significant interaction of Maternal Diet x Drug on PPI scores (F1,36=5.57, 
p=0.02,  Fig. 3). DVD-deficient rats had enhanced PPI scores after 2.5 mg/kg THC 
compared with control rats (p=0.006), or within-subject treatment compared with 
vehicle (p=0.009). THC administration had no effect on PPI in control animals. 
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<<Insert Fig. 3 near here>> 
 
Effect of THC on open field activity 
There was no significant effect of Maternal Diet (F1,43=0.1, p=0.7) or THC (F1,43=0.06, 
p=0.8) on the distance travelled in the open field after vehicle (Fig. 4). Control and 
DVD-deficient rats also showed a similar decrease in locomotor activity over 90 min 
after THC injection.  
 
<<Insert Fig. 4 near here>> 
 
Discussion 
The main findings of this study were that acute administration of THC led to a 
reduction in performance on the DMTS at the highest dose tested (2.5 mg/kg) and 
there was no significant effect of Maternal Diet on working memory at baseline or 
after acute THC. In separate groups of rats, 2.5 mg/kg THC led to enhanced PPI in 
DVD-deficient rats, and this was not seen in control rats. Finally, there were no 
significant effects of Maternal Diet or 2.5 mg/kg THC on ASR or on locomotion.  
 
A core feature of schizophrenia is deficits in cognitive domains, such as working 
memory and attentional processing. We used the DMTS task to investigate delay-
dependent memory in THC-treated DVD-deficient rats. We have previously shown 
maternal diet affects tasks of attentional processing, such as the 5 choice continuous 
performance test (Turner et al., 2013). However, in the current study there were no 
significant effects of Maternal Diet on DMTS performance either at baseline or after 
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THC administration. Accuracy decreased with longer delays, demonstrating that the 
task was measuring a delay-dependent memory. However, at the highest dose, 2.5 
mg/kg, THC reduced percent correct responses at the 0 s delay, which means that 
there were non-specific effects of THC on performance of the task with respect to 
procedural memory and/or it produced a general disruption in behaviour in addition 
to delay-dependent memory. One limitation of the current DMTS experiment was 
that we used an escalating dose schedule with each dose tested only once, and 
vehicle-treated rats were not tested on the same days as rats treated with THC. It is 
possible that the effects at the highest dose could be a result of this escalation to 
that dose. Low sample sizes could also have affected our ability to detect any 
hypersensitivity of DVD-deficient rats to THC-induced delay-dependent memory 
deficits and independent replication would be required to confirm these findings. 
Previous studies of THC on DMTS have shown that 2.5 mg/kg THC in Sprague-
Dawley rats led to delay-dependent impairment in performance on a DMTS task, 
with no effect on accuracy at the 0s delay (Heyser et al., 1993). In Long Evans rats 3 
mg/kg THC also produced a delay-dependent impairment in accuracy using a 
DNMTS procedure (Panlilio et al., 2012), whereas a higher dose (5.6 mg/kg) was 
shown to significantly decrease accuracy at all delays (0-28s) on the DNMTS 
(Panlilio et al., 2011). In another study it was shown that 2 mg/kg THC in Wistar rats 
led to a delay-dependent decrease in accuracy on a DNMTS task, and at a higher 
dose (4 mg/kg) there was an increase in the number of null trials (Mallet & Beninger, 
1998). In the current study we saw a significant increase in the percent of null trials 
at 2.5 mg/kg, suggesting that doses which impair delay-dependent memory may also 
induce a motor impairment.  
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There was no significant effect of Maternal Diet on locomotion in the open field after 
either vehicle or THC. DVD-deficient rats have been shown to have enhanced 
novelty-induced locomotion on a range of tasks including the hole board and 
elevated plus maze (Burne et al., 2004). We have shown this enhanced response 
can be attenuated with handling procedures and injections (Burne et al., 2004; 
Kesby et al., 2006), and this was also seen in the current study. DVD-deficiency did 
not induce any baseline ASR or PPI deficit, which replicates previous results in this 
model (Burne et al., 2004; Kesby et al., 2012). However, THC led to enhanced PPI in 
DVD-deficient but not control rats at the same dose that disrupted performance on 
the DMTS. The neurobiology behind working memory and a pre-attentive task, such 
as PPI, are dissociable although there is overlap in the neural circuitry involved 
(Koch 1999). We do not show an effect of 2.5 mg/kg THC on ASR or locomotion in 
control or DVD-deficient rats, therefore, the interpretation of enhanced PPI seen here 
is not potentially confounded by THC-induced disruptions to ASR as seen in other 
studies (Malone & Taylor, 2006; Nagai et al., 2006). The mechanism of action of how 
cannabinoids affect working memory may be due to the action of THC on the 
mesolimbic dopamine system (Vadhan et al., 2009), which is also a common 
neuronal substrate for the rewarding properties of drugs of abuse. Although there are 
many possible explanations as to how THC affects PPI it may be similarly via its 
downstream effects on dopaminergic pathways. DVD-animals display a number of 
abnormalities in DA-related behaviours as adults (Kesby et al., 2010; Kesby et al., 
2013).  
 
The aetiology of schizophrenia is affected by interactions between environmental 
and genetic susceptibility factors. Acute THC exposure is thought to precipitate 
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psychosis in vulnerable individuals and like other psychotomimetic drugs, such as 
amphetamine, disrupt PPI. For example, socially isolated, but not group-housed, rats 
show impaired PPI after acute administration of 3 mg/kg THC [23]. Neuregulin 1 is a 
candidate susceptibility gene for schizophrenia (Stefansson et al., 2002) and 
transmembrane domain neuregulin 1 heterozygous (Nrg1) mice show altered 
sensitivity to the behavioural effects of acute administration of THC. However, unlike 
socially-isolated rats, PPI was enhanced in male Nrg1 heterozygous mice after acute 
treatment (Boucher et al., 2007; Long et al., 2010b) and female Nrg1 heterozygous 
mice after chronic treatment (Long et al., 2010a; Long et al., 2013), compared with 
wildtype controls. A similar result of enhanced PPI was reported following 
administration of the CB receptor agonist CP55,940 in mice heterozygous for BDNF 
(Klug & van den Buuse, 2013), and in Wistar rats (Stanley-Cary et al., 2002). The 
latter study showed that 5% ethanol can reverse the effects of CP55,940. However, 
we used Tween 80 and 5% ethanol to dissolve THC and this was also used in the 
vehicle to control for these effects (Stanley-Cary et al., 2002). There appears to be 
highly contrasting effects of acute treatment of CB agonists on PPI. For example, 
inbred ddY mice treated with 6 mg/kg THC were shown to have impairments in both 
PPI and ASR (Nagai et al., 2006). Therefore, it appears that THC can enhance or 
impair PPI depending on the background genotype (i.e. Nrg1 (Boucher et al., 2007)) 
and prior handling conditions (i.e. social isolation (Malone & Taylor, 2006)). 
 
Although psychotic disorders are commonly characterized by impairments of 
sensorimotor gating (Braff et al., 2001), drugs, such as nicotine, have been shown to 
enhance PPI in healthy controls and patients with schizophrenia (Hong et al., 2008; 
Kodaira et al., 2013). Cannabis users have been shown to have altered PPI, 
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although the deficit may be different to that observed in patients with schizophrenia, 
which suggests that PPI impairments may be a result of deficits in selective 
attention, rather than deficits in preattentive processes (Scholes & Martin-Iverson, 
2009). However, most people who use cannabis do not develop psychosis 
(Mazzoncini et al., 2010), and those who do are likely to be exposed to increased 
genetic or environmental risk factors (Henquet et al., 2008). Mindful that our results 
need replication, our findings suggest that the pathways mediating PPI are more 
vulnerable to THC in the DVD-deficient rat model. Clearly studies using more chronic 




The DVD-deficiency model produces offspring that share many structural (Feron et 
al., 2005) and behavioral (Becker et al., 2005) similarities with patients who develop 
schizophrenia. In addition these animals are also selectively sensitive to the PPI 
enhancing effects of THC. This study represents the first pharmacological 
investigation of THC on behavior in DVD-deficient rats. These findings add further 
support to the hypothesis that developmental vitamin D deficiency affects brain 
development and suggest that cannabinoid systems in particular may be targeted by 
this exposure.  
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Titles and legends to figures 
 
Fig. 1 There was no significant effect of Maternal Diet on performance on the DMTS 
task in response to acute THC administration. There was impaired performance with 
the highest dose of THC used in both control (A, n=16) and DVD-deficient rats (C, 
n=13) * p<0.05 compared to Vehicle. Performance was impaired at the 0 s delay 
suggesting THC was not selectively affecting working memory 
 
Fig. 2 Responses of control and DVD-deficient rats on the DMTS task in response to 
acute THC administration measured as (A) percent correct and (B) percent of null 
trials. The baseline stability of responding is shown in (C) which presents percent 
correct responses after vehicle treatment on sessions given between drug sessions. 
* p<0.05 compared to Vehicle 
 
Fig. 3 Maternal Diet increases PPI (B, D), with no affect on ASR (A, C), after acute 
administration of 2.5 mg/kg THC * p<0.05. There was no effect of Maternal Diet on 
the PPI scores after vehicle treatment. 
 
Fig. 4 There was no significant effect of Maternal Diet on locomotion scores in the 
open field after acute administration of either vehicle (A) or 2.5 mg/kg THC (B). 
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